China Cord Blood (CO) Is Today's Strong On High Volume Stock
at The Street - Wed Apr 22, 9:06AM CDT
Trade-Ideas LLC identified China Cord Blood (CO) as a strong on high relative volume candidate
CO: 6.42 (-0.05)
28.7% Return Seen to Date on SmarTrend China Cord Blood Call (CO)
Comtex SmarTrend(R) - Tue Apr 21, 11:34AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 3 months, China Cord Blood has returned 28.72% as of today's recent price of $6.32.
CO: 6.42 (-0.05)
American Eagle Outfitters and Make It Right Launch National Denim Recycling Program for Earth Day
Business Wire - Mon Apr 20, 9:38AM CDT
In honor of Earth Day, Make It Right is kicking off a partnership with leading apparel company American Eagle Outfitters to recycle used and unwanted denim into building materials for affordable homes.
AEO: 16.93 (unch), CO: 6.42 (-0.05)
China Cord Blood: Attractive Buyout Target With 22.4% Upside And Minimal Bloodletting
Jennifer Wang - at Seeking Alpha - Thu Apr 16, 1:53PM CDT
CO: 6.42 (-0.05)
17.1% Return Seen to Date on SmarTrend China Cord Blood Call (CO)
Comtex SmarTrend(R) - Tue Apr 14, 10:32AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 17.11% as of today's recent price of $5.75.
CO: 6.42 (-0.05)
Uptrend Call Working As China Cord Blood Stock Rises 23.0% (CO)
Comtex SmarTrend(R) - Tue Apr 07, 9:24AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 23.01% as of today's recent price of $6.04.
CO: 6.42 (-0.05)
Shares of CO Up 15.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 30, 10:08AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 15.48% as of today's recent price of $5.67.
CO: 6.42 (-0.05)
BUYINS.NET: ENS, EOC, AUO, CO, IDT, DPZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Mar 27, 7:52AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of EnseCo Energy Services Corp (NYSE:ENS), Empresa Nacional de Electricidad SA (NYSE:EOC), AU Optronics Corp (NYSE:AUO), China Cord Blood Corp (NYSE:CO), IDT Corp (NYSE:IDT), Domino's Pizza Inc (NYSE
AUO: 5.04 (+0.10), IDT: 17.66 (unch), DPZ: 99.80 (+0.40), CO: 6.42 (-0.05), EOC: 46.48 (-0.47), ENS: 68.26 (+0.19)
China Cord Blood (CO) Worth Watching: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 8:25AM CDT
China Cord Blood (CO) was a big mover last session, with shares rising over 7% on the day.
CHE: 122.49 (+0.25), CO: 6.42 (-0.05)
CEOs Just Can't Let Go of the Company Jet for Personal Use – Even When They Should
at The Street - Mon Mar 23, 10:59AM CDT
In times of trouble, one might think companies would be quick to squeeze the personal corporate jet perk for CEOs from their budgets. But many are holding on tight.
GE: 26.91 (+0.29), NKE: 100.15 (-0.14), UTX: 116.96 (+0.01), C: 53.10 (+0.62), CHTR: 184.88 (-1.93), WFC: 54.67 (+0.39), MHFI: 104.25 (+0.69), BA: 151.19 (-2.14), PEP: 97.28 (+0.50), CI: 130.25 (-0.45), GS: 198.32 (+1.48), IBM: 165.36 (+1.10), TGT: 81.34 (+0.09), CO: 6.42 (-0.05)
Shares of CO Up 23.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 23, 9:33AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 23.83% as of today's recent price of $6.08.
CO: 6.42 (-0.05)
An Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
PR Newswire - Thu Mar 19, 11:24AM CDT
The following is an open letter sent March 19, 2015 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital.
CO: 6.42 (-0.05)
China Cord Blood's (CO) CEO Tina Zheng on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 12:28PM CST
CO: 6.42 (-0.05)
China Cord Blood Corp (CO) Jumps: Stock Up 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 8:25AM CST
China Cord Blood Corp (CO) was a big mover last session, with shares rising over 9% on the day.
CO: 6.42 (-0.05), AMED: 26.07 (+0.03)
How it All Plays Out: Special Research on Global Defense & National Security Systems, HF2 Financial Management, American Apparel, JetPay, and CCBC
PR Newswire - Tue Feb 17, 8:20AM CST
Editor Note: For more information about this release, please scroll to bottom.
APP: 0.65 (-0.03), GDEF: 10.43 (-0.05), JTPY: 3.24 (-0.01), CO: 6.42 (-0.05), HTWO: 9.70 (-0.11)
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2015 Financial Results
PR Newswire - Tue Feb 17, 6:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company"
CO: 6.42 (-0.05)
Keep An Eye On China Cord Blood
Jack Banser - at Seeking Alpha - Tue Feb 10, 8:19AM CST
CO: 6.42 (-0.05)
China Cord Blood Corporation and Cord Blood Registry Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
China Cord Blood Corporation (CCBC, NYSE: CO), China's first and largest umbilical cord blood bank, and Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 6.42 (-0.05)
Cord Blood Registry and China Cord Blood Corporation Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, and China Cord Blood Corporation (CCBC [NYSE: CO]), China's first and largest umbilical cord blood bank, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 6.42 (-0.05)